Evaluation of Patients with Fibrotic Interstitial Lung Disease: Preliminary results from the Turk-UIP Study

Date
2021
Author
Ebru, Cakir Edis
Hatice, Turker
Banu, Salepci
Armagan, Hazar
Yelda, Niksarlioglu Elif
YILMAZ KARA, BİLGE
KÖKTÜRK, NURDAN
Fusun, Kalpaklioglu
Isil, Uzel
Savas, Ozsu
Ersan, Atahan
Zeynep, Fendoglu Turkan
Sureyya, Yilmaz
Ilknur, Basyigit
Gungor, Camsari
Esin, Tuncay
Elif, Ucar Yilmazel
Dilek, Kanmaz
Aydanur, Ekici
Fusun, Topcu
Esra, Uzaslan
Fulsen, Bozkus
ARGUN BARIŞ, SERAP
Serap, Duru
Goksel, Altinisik
Zuleyha, Bingol
Atadan, Tunaci
SAVAŞ, RECEP
Fatih, Alper
Selen, Bayraktaroglu
Tuba, Selcuk Can
Arslan, Demir Ali
Benan, Musellim
Nesrin, Mogulkoc
Oguz, Uzun
Fatma, Tokgoz Akyil
Haluk, Turktas
Ozlem, Ozdemir Kumbasar
Gulfer, Okumus
Candan, Ogus
Hulya, Dirol
Adil, Zamani
Tulin, Sevim
Nihat, Annakkaya Ali
Akinci, Ozyurek Berna
Ismail, Hanta
Yusuf, Aydemir
Bahar, Kurt
Can, Tertemiz Kemal
Levent, Tabak
Onur, Yazici
Yurdanur, Erdogan
Gungor, Ates
Metadata
Show full item record
Abstract
OBJECTIVE: Differential diagnosis of idiopathic pulmonary fibrosis (IPF) is important among fibrotic interstitial lung diseases (ILD). This study aimed to evaluate the rate of IPF in patients with fibrotic ILD and to determine the clinical-laboratory features of patients with and without IPF that would provide the differential diagnosis of IPF.
URI
http://hdl.handle.net/20.500.12627/171402
https://doi.org/10.5152/turkthoracj.2021.20028
Collections